Overall, for treatment of hyperglycaemia, metformin remains the agent of choice in most people with diabetes, based on its glucose-lowering efficacy, minimal risk of hypoglycaemia, lack of weight increase and affordability
3094 ( MDL 3094 )
For patients struggling with obesity, metabolic syndrome, or PCOS, improving metabolic health may support reproductive function
Start your intake Week 14: When Tirzepatide Effects First Appear During the first month of tirzepatide therapy, your body begins adapting to the medication's appetite-suppressing signals
Semaglutide offers a promising solution for individuals struggling with type 2 diabetes and obesity
To view a copy of this licence, visit About this article Cite this article Sun, L., Liu, H., Zhang, X